Pharmacokinetic and pharmacodynamic considerations for drugs binding to alpha-1-acid glycoprotein

SA Smith, NJ Waters - Pharmaceutical research, 2019 - Springer
According to the free drug hypothesis only the unbound drug is available to act at
physiological sites of action, and as such the importance of plasma protein binding primarily …

Formulation optimization and biopharmaceutical evaluation of imatinib mesylate loaded β-cyclodextrin nanosponges

M Kamble, Z Zaheer, S Mokale… - Pharmaceutical …, 2019 - ingentaconnect.com
Background: Many researchers have prepared and evaluated nanosponges and claimed
their advantages as an effective drug carrier, especially it was observed prominently in case …

Theramutein modulators

GM Housey - US Patent 10,471,065, 2019 - Google Patents
This invention relates to agents that are inhibitors or acti vators of variant forms of
endogenous proteins and novel methods of identifying such variants. Of particular interest …

Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators

GM Housey, ME Balash - US Patent 10,473,643, 2019 - Google Patents
COJUAWICINQKFR-OHUIHDMLSA-N O= C (NC1= CC= CC (C (F)(F) F)= C1) C1= CC (/C=
N\NC2= NC (N3CCOCC3)= C (F) C= N2)= C (O) C (Cl)= C1 Chemical compound O= C …

[PDF][PDF] Monitorización farmacoterapéutica de inhibidores de tirosina quinasa en pacientes oncológicos

VD Leñero, VE Ortiz, DAB Masllorens - 2019 - core.ac.uk
Conclusiones: Erlotinib, imatinib, lapatinib, pazopanib, sorafenib y sunitinib, muestran gran
variabilidad interindividual en su exposición con altos porcentajes de variación en los …